Researchers at Kennedy Krieger Institute report that Transcutaneous Spinal Cord Stimulation (TSS) combined with movement ...

BALTIMORE, November 12, 2024— Researchers at Kennedy Krieger Institute's International Center for Spinal Cord Injury (ICSCI) have made a remarkable advancement in treating children with Acute Flaccid ...

Researchers at Kennedy Krieger Institute's International Center for Spinal Cord Injury (ICSCI) have made a remarkable advancement in treating children with Acute Flaccid Myelitis (AFM), a rare but ...

Researchers at Kennedy Krieger Institute's International Center for Spinal Cord Injury (ICSCI) have made a remarkable ...

Sessions that focused on diagnosis and acute treatment of rare neuroimmune disorders (RNDs). A panel of people with these ...

PP-007 is a unique combination of a carbon monoxide releasing molecule and an oxygen transfer agent. The Food and Drug Administration (FDA) has granted Fast Track designation to PP-007 (PEGylated ...

When this fluid cannot drain, it allows for the growth of bacteria and viruses in the ear that can lead to acute otitis media. The following are some of the reasons that the eustachian tube may not ...

The World Health Organization (WHO) convened the inaugural meeting of the Acute Care Action Network (ACAN) on 17–18 October in Geneva, Switzerland. The gathering brought together key stakeholders to ...

Reports of GLP-1RA–associated acute kidney injury (AKI) have emerged, but the risk of GLP-1RA–associated AKI among patients on anti-cancer drugs is unclear. Surprisingly, new research suggests ...

Circle to Search is coming to compatible phones with OxygenOS 15 The update also adds new boot animation, icons, and shelf card choices OxygenOS 15 introduces Gemini-powered AI Notes ...

But a new study from NDORMS shows that post-acute infection syndrome (PAIS) is not unique to COVID-19 and can also occur after other respiratory infections. The research, led by Dr. Junqing Xie ...

SEONGNAM, South Korea, October 25, 2024--(BUSINESS WIRE)--Qurient Co. Ltd. (KRX: 115180) has announced the commencement of a clinical trial for adrixetinib (formerly named Q702), following the ...